
Laura Lynne Stockton
Examiner (ID: 114, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1646, 1626, 1201, 1614, 2899, 1613 |
| Total Applications | 3245 |
| Issued Applications | 2194 |
| Pending Applications | 342 |
| Abandoned Applications | 753 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18346253
[patent_doc_number] => 20230134363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => ORGANIC COMPOUND AND SENSOR AND SENSOR EMBEDDED DISPLAY PANEL AND ELECTRONIC DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/954986
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17954986
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/954986 | ORGANIC COMPOUND AND SENSOR AND SENSOR EMBEDDED DISPLAY PANEL AND ELECTRONIC DEVICE | Sep 27, 2022 | Pending |
Array
(
[id] => 18405776
[patent_doc_number] => 20230167127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/934968
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 615
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934968
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934968 | COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTION | Sep 22, 2022 | Pending |
Array
(
[id] => 18223981
[patent_doc_number] => 20230062975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HEPATITIS B CAPSID ASSEMBLY MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/947593
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/947593 | HEPATITIS B CAPSID ASSEMBLY MODULATORS | Sep 18, 2022 | Abandoned |
Array
(
[id] => 18213745
[patent_doc_number] => 20230060011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => ANTIBACTERIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/946587
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946587 | Antibacterial compounds | Sep 15, 2022 | Issued |
Array
(
[id] => 19226693
[patent_doc_number] => 12006326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Antiviral heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/894412
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50601
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/894412 | Antiviral heterocyclic compounds | Aug 23, 2022 | Issued |
Array
(
[id] => 18253835
[patent_doc_number] => 20230080874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => TROPOMYOSIN-RELATED KINASE (trk) INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/883350
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17883350
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/883350 | Tropomyosin-related kinase (Trk) inhibitors | Aug 7, 2022 | Issued |
Array
(
[id] => 18036098
[patent_doc_number] => 20220380313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED AROMATIC HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/815064
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815064 | Method for producing difluoromethyl-substituted aromatic heterocyclic compound | Jul 25, 2022 | Issued |
Array
(
[id] => 19904087
[patent_doc_number] => 12281083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
[patent_app_type] => utility
[patent_app_number] => 17/862290
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18015
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 413
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862290 | 2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof | Jul 10, 2022 | Issued |
Array
(
[id] => 19311550
[patent_doc_number] => 12037353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Carbon capture, storage, and recycling compositions
[patent_app_type] => utility
[patent_app_number] => 17/861740
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 4167
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861740
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861740 | Carbon capture, storage, and recycling compositions | Jul 10, 2022 | Issued |
Array
(
[id] => 18209944
[patent_doc_number] => 20230056205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SUBSTITUTED 4,6-DIHYDROSPIRO[[1,2,3]TRIAZOLO[4,5-B]PYRIDINE-7,3'-INDOLINE]-2',5(3H)-DIONE ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 17/856915
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856915 | Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues | Jun 30, 2022 | Issued |
Array
(
[id] => 18347784
[patent_doc_number] => 20230135894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => MK2 DEGRADERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/855336
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855336 | MK2 DEGRADERS AND USES THEREOF | Jun 29, 2022 | Abandoned |
Array
(
[id] => 18213738
[patent_doc_number] => 20230060004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => DIACYLGLYERCOL KINASE MODULATING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/845469
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845469 | Diacylglycerol kinase modulating compounds | Jun 20, 2022 | Issued |
Array
(
[id] => 17882650
[patent_doc_number] => 20220298127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => BICYCLIC HETEROARYL DERIVATIVES AND PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/835106
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835106 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Jun 7, 2022 | Issued |
Array
(
[id] => 19013003
[patent_doc_number] => 11919918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/826711
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35522
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826711
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826711 | P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof | May 26, 2022 | Issued |
Array
(
[id] => 17882677
[patent_doc_number] => 20220298154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PYRAZOL-3-ONES THAT ACTIVATE PRO-APOPTOTIC BAX
[patent_app_type] => utility
[patent_app_number] => 17/826479
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826479 | PYRAZOL-3-ONES THAT ACTIVATE PRO-APOPTOTIC BAX | May 26, 2022 | Abandoned |
Array
(
[id] => 18366402
[patent_doc_number] => 20230147993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => THIOPHENE COMPOUNDS WITH CYCLIC AMIDES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/743234
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743234 | THIOPHENE COMPOUNDS WITH CYCLIC AMIDES, AND USES THEREOF | May 11, 2022 | Abandoned |
Array
(
[id] => 17853128
[patent_doc_number] => 20220283170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/742378
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742378 | COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | May 10, 2022 | Pending |
Array
(
[id] => 17960001
[patent_doc_number] => 20220340581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/719653
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719653 | Compounds and pharmaceutical compositions thereof for the treatment of diseases | Apr 12, 2022 | Issued |
Array
(
[id] => 18282772
[patent_doc_number] => 20230098244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => SUBSTITUTED INDOLE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/699944
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699944 | Substituted indole compounds | Mar 20, 2022 | Issued |
Array
(
[id] => 17913219
[patent_doc_number] => 20220315614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => REDUCING AGENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/698283
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698283 | Reducing agents and uses thereof | Mar 17, 2022 | Issued |